Nurse Telephone Follow-up for Cardiovascular Patients (Nurse-TEL-CVD)

August 6, 2025 updated by: Hossein Mohsenipouya, Mazandaran University of Medical Sciences

Evaluation the Effect of "Nurse Telephone Follow-up" on Depression, Anxiety and Stress and Readmission of Cardiovascular Patients in Hospitalized Patients in Mazandaran Province

This study aims to evaluate the effect of follow-up telephone education provided by a nurse on the levels of anxiety, stress, and depression in patients hospitalized in the cardiac intensive care unit during the two weeks after discharge. Patients will be randomly assigned to either the intervention (education) group or the control group. Their levels of anxiety, stress, and depression will be measured before and after the intervention. The aim is to determine whether this educational intervention can improve the psychological well-being of these patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Informed consent obtained from both the patient and their family.
  2. Definite diagnosis of heart disease confirmed by a specialist physician.
  3. No previous history of psychological problems, based on the patient's medical records.
  4. No prior participation in similar educational programs.

Exclusion Criteria:

  1. Non response to the nurse's follow-up calls.
  2. Failure to complete the survey.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
Patients receive telephone follow-up education by nurse.
Behavioral: Telephone Education
Participants in this group will receive telephone follow-up education by a nurse during the two weeks after discharge
Active Comparator: Control Group
Patients receive usual care without follow-up education.
Behavioral: Standard Care (in control arm)
Participants in this group will receive standard post-discharge care without any follow-up telephone education

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression, Anxiety, stress Score(DASS-21)
Time Frame: 2 weeks after discharge
Changes in depression, anxiety, stress scores as measured by DASS-21
2 weeks after discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mazandaran University of Medical Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 23, 2023

Primary Completion (Actual)

December 21, 2023

Study Completion (Actual)

December 21, 2023

Study Registration Dates

First Submitted

August 6, 2025

First Submitted That Met QC Criteria

August 6, 2025

First Posted (Actual)

August 13, 2025

Study Record Updates

Last Update Posted (Actual)

August 13, 2025

Last Update Submitted That Met QC Criteria

August 6, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IR.MAZUMS.REC.1401.269 (Other Identifier: Mazandaran University of Medical Sciences, Ethics Committee)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared for this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe